|
|
|
MALAWI: Local manufacture of anti-AIDS drugs considered
[This report does not necessarily reflect the views of the United Nations]
JOHANNESBURG, 13 July (PLUSNEWS) - Malawi says it is considering the local production of generic antiretrovirals to ensure an affordable and sustainable supply.
According to Malawian Health Minister Hetherwick Ntaba, the stricter patent laws recently passed in India were threatening his country's supply of low-cost versions of the life-prolonging drugs.
Malawi began rolling out free anti-AIDS drugs last year, receiving most of its requirements from Indian generic drug manufacturers Ranbaxy Laboratories and Cipla, with funding from the Global AIDS Fund.
Ntaba told London's Financial Times that after Ranbaxy and Cipla removed some of their antiretrovirals from the World Health Organisation's list of prequalified medications, his country had to wait up to three months to find a new supply.
[ENDS]
MORE NEWS BRIEFS
|
|
|
|
|
|
|
| Links |
Le portail d'informations générales de la Côte d’Ivoire
|
Sida Info Services
|
Le Fonds mondial de lutte contre le SIDA, la tuberculose et le paludisme
|
Le Réseau Afrique 2000
|
The Global Fund to fight AIDS, Tuberculosis & Malaria
|
|
PlusNews does not take responsibility for info in links supplied.
|
|
|
|
|
[Back] [Home Page]
Click here to send any feedback, comments or questions you have about PlusNews Website or if you prefer you can send an Email to Webmaster
Copyright © IRIN 2005
The material contained on www.PlusNews.org comes to you via IRIN, a UN humanitarian news and information service, but may not necessarily reflect the views of the United Nations or its agencies.
All PlusNews material may be reposted or reprinted free-of-charge; refer to the IRIN copyright page for conditions of use. IRIN is a project of the UN Office for the Coordination of Humanitarian Affairs.
|
